Pharmacologic treatment of attention-deficit hyperactivity disorder

被引:9
作者
Donald E. Greydanus
机构
[1] Michigan State University,Pediatrics and Human Development
[2] Kalamazoo Center for Medical Studies Kalamazoo,undefined
关键词
Attention deficit hyperactivity disorder; Methylphenidate; Amphetamines; Atomoxetine; Bupropion;
D O I
10.1007/BF02731672
中图分类号
学科分类号
摘要
Attention-deficit hyperactivity disorder (ADHD) is highly prevalent in children and adolescents. Highly effective pharmacological treatments are available that allow the child and the adolescent to function at his/her full potential. Various preparations of methylphenidate and amphetamines have been used for a long time in the treatment of ADHD. This article reviews these and some of the newer drugs used in the treatment of ADHD, including atomoxetine and bupropion.
引用
收藏
页码:953 / 960
页数:7
相关论文
共 36 条
[1]  
Greydanus DE(2002)Psychopharmacology of ADHD in adolescents Adolesc Med 13 599-624
[2]  
Sloane MA(2003)Attention-deficit/ hyperactivity disorder in Children and adolescents: Interventions for a complex costly clinical conundrum Pediatr Clin North Am 50 1049-1092
[3]  
Rappley MD(2003)Psychopharmacology of ADHD in adolescents: Quo vadis? Psychiatr Times 20 5-9
[4]  
Greydanus DE(1998)Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder NIH Consensus Statement Online 16 1-37
[5]  
Pratt HD(2002)Neurodevelopmental Issues in the assessment and treatment of deficits in attention, cognition, and learning during adolescence Adolesc Med 13 579-598
[6]  
Sloane MA(2003)ADHD evaluation and diagnosis: A practical approach to office practice Pediatr Clin North Am 50 1019-1048
[7]  
Greydanus DE(2005)Attention-devicit/hyperactivity disorder psychopharmacology for college students Pediatr Clin North Am 52 71-84
[8]  
Pratt HD(2005)ADHD: A review Pediatrics 115 749-757
[9]  
Reiff MI(2004)ADHD: The diagnostic process from different perspectives Dev Behav Pediatr 25 53-57
[10]  
Stein MT(2004)National Institute of Mental Health Multimodal Treatment Study of ADHD Follow-up: Changes in effectiveness and growth after the end of treatment Pediatrics 113 762-769